Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00005811
First received: June 2, 2000
Last updated: February 20, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)